These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35887744)

  • 1. Correlation Analysis between Intraocular Pressure and Extraocular Muscles Based on Orbital Magnetic Resonance T2 Mapping in Thyroid-Associated Ophthalmopathy Patients.
    Luo B; Wang W; Li X; Zhang H; Zhang Y; Hu W
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid-Associated Ophthalmopathy: Preliminary Study Using T2 Mapping to Characterize Intraorbital Optic Nerve Changes Before Dysthyroid Optic Neuropathy.
    Hu H; Chen HH; Chen W; Wu Q; Chen L; Zhu H; Shi HB; Xu XQ; Wu FY
    Endocr Pract; 2021 Mar; 27(3):191-197. PubMed ID: 33630733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of extraocular muscles in patients with thyroid associated ophthalmopathy using apparent diffusion coefficient measured by magnetic resonance imaging before and after radiation therapy.
    Yu W; Zheng L; Shuo Z; Xingtong L; Mengda J; Lin Z; Ziyang S; Huifang Z
    Acta Radiol; 2022 Sep; 63(9):1180-1186. PubMed ID: 34338029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of extraocular muscles for intraocular pressure in thyroid-associated ophthalmopathy patients.
    Tian H; Wang Y; Li J; Li H
    Quant Imaging Med Surg; 2023 Sep; 13(9):5727-5736. PubMed ID: 37711835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study.
    Gao Y; Chang Q; Li Y; Zhang H; Hou Z; Zhang Z; Li Z; Li D
    BMC Ophthalmol; 2022 Feb; 22(1):66. PubMed ID: 35144579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular hypertension in patients with active thyroid-associated orbitopathy: a predictor of disease severity, particularly of extraocular muscle enlargement.
    Karhanová M; Kalitová J; Kovář R; Schovánek J; Karásek D; Čivrný J; Hübnerová P; Mlčák P; Šín M
    Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3977-3984. PubMed ID: 35834036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION.
    Zhou M; Shen L; Jiao Q; Ye L; Zhou Y; Zhu W; Wang W; Wang S
    Endocr Pract; 2019 Dec; 25(12):1268-1278. PubMed ID: 31412229
    [No Abstract]   [Full Text] [Related]  

  • 8. Dixon MRI-based quantitative parameters of extraocular muscles, intraorbital fat, and lacrimal glands for staging thyroid-associated ophthalmopathy.
    Pu XY; Chen L; Hu H; Wu Q; Jiang WH; Lu JL; Chen HH; Xu XQ; Wu FY
    Insights Imaging; 2024 Jun; 15(1):136. PubMed ID: 38853188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
    Wu T; Tang DR; Wang F; Xia S; Sun FY
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity.
    Higashiyama T; Iwasa M; Ohji M
    Sci Rep; 2017 Dec; 7(1):16874. PubMed ID: 29203853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
    Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of treatment response to intravenous glucocorticoid in patients with thyroid-associated ophthalmopathy using T2 mapping and T2 IDEAL.
    Zhai L; Luo B; Wu H; Wang Q; Yuan G; Liu P; Ma Y; Zhao Y; Zhang J
    Eur J Radiol; 2021 Sep; 142():109839. PubMed ID: 34252869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles].
    Yang M; Du BX; Wang YJ; He WM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):510-515. PubMed ID: 34018373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg.
    Politi LS; Godi C; Cammarata G; Ambrosi A; Iadanza A; Lanzi R; Falini A; Bianchi Marzoli S
    Eur Radiol; 2014 May; 24(5):1118-26. PubMed ID: 24519110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Inferior Rectus Muscle Thickening on Intraocular Pressure in Thyroid-Associated Ophthalmopathy.
    Li X; Bai X; Liu Z; Cheng M; Li J; Tan N; Yuan H
    J Ophthalmol; 2021; 2021():9736247. PubMed ID: 33564471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2 Relaxation Time in Extraocular Muscles of Patients with Mild Thyroid- Associated Ophthalmopathy: Comparing T2 Mapping With and Without Fat Suppression Using Different Measurement Methods.
    Li D; Guo X; Zeng J; Feng H; Zhu T; Li H
    Curr Med Imaging; 2024; 20():e15734056299907. PubMed ID: 38639286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of T2 mapping in the staging of thyroid-associated ophthalmopathy: efficiency of region of interest selection methods.
    Chen W; Hu H; Chen HH; Su GY; Yang T; Xu XQ; Wu FY
    Acta Radiol; 2020 Nov; 61(11):1512-1519. PubMed ID: 32053002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fat-suppression T2 relaxation time and water fraction predict response to intravenous glucocorticoid therapy for thyroid-associated ophthalmopathy.
    Zhai L; Li F; Luo B; Wang Q; Wu H; Zhao Y; Yuan G; Zhang J
    Eur Radiol; 2024 Aug; ():. PubMed ID: 39093414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Volumetric T2 Relaxation Time Histogram Analysis: Can It Be Used to Predict the Response to Intravenous Methylprednisolone Therapy in Patients With Thyroid-Associated Ophthalmopathy?
    Liu P; Luo B; Chen L; Wang QX; Yuan G; Jiang GH; Zhang J
    Front Endocrinol (Lausanne); 2021; 12():614536. PubMed ID: 33716970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of radiotherapy on moderate and severe thyroid associated ophthalmopathy: a double blind and self-controlled study.
    Wu Y; Tong B; Luo Y; Xie G; Xiong W
    Int J Clin Exp Med; 2015; 8(2):2086-96. PubMed ID: 25932139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.